Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: Implications for prevention of CMV transmission

Transplantation

Volumn 65, Issue 3, 1998, Pages 411-415

  Larsson, Susanne ^a,b   Söderberg Nauclér, Cecilia ^a,c   Möller, Erna ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; INFECTION RISK; LATENT VIRUS INFECTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD13; BLOOD DONORS; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; POSTOPERATIVE COMPLICATIONS; REFERENCE VALUES;

EID: 0344588828     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802150-00021     Document Type: Article

References (31)

1. Adler SP. Transfusion-associated cytomegalovirus infections. Rev Infect Dis 1983; 5(6): 977.
2. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990; 12(7): S701.
3. Gilbert GL, Hayes K, Hudson IL, James J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989; 1(8649): 1228.
4. van Prooijen HC, Visser JJ, van Oostendorp WR, de Gast GC, Verdonck LF. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. Br J Haematol 1994; 87(1): 144.
5. Bowden RA. Transfusion-transmitted cytomegalovirus infection [Review]. Hematol Oncol Clin N Am 1995; 9(1): 155.
6. Bowden RA, Sayers M, Flournoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986; 314(16): 1006.
7. Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 1991; 78(1): 246.
8. Ljungman P, Aschan J, Hägglund H, et al. Screened CMV negative blood products versus filtered blood products in CMV seronegative BMT patients with seronegative donors: infection rate evaluated by leukocyte based PCR. Sixth International Cytomegalovirus Workshop. Perdido Beach Resort, Orange Beach, AL, 1997.
9. Miller WJ, McCullough J, Balfour H Jr, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 1991; 7(3): 227.
10. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86(9): 3598.
11. Schrier RD, Nelson JA, Oldstone MB. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 1985; 230(4729): 1048.
12. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991; 65(12): 6581.
13. Söderberg C, Larsson S, Bergstedt-Lindqvist S, Möller E. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol 1993; 67(6): 3166.
14. - alovirus in peripheral blood mononuclear cells. J Gen Virol 1991; 72(pt 9): 2059.
15. Jordan MC. Latent infection and the elusive cytomegalovirus. Rev Infect Dis 1983; 5(2): 205.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162(1): 156.
17. Akrigg A, Wilkinson GW, Oram JD. The structure of the major immediate early gene of human cytomegalovirus strain AD169. Virus Res 1985; 2(2): 107.
18. Jahn G, Kouzarides T, Mach M, et al. Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. J Virol 1987; 61(5): 1358.
19. Chen EY, Cheng A, Lee A, et al. Sequence of human glucose-6-phosphate dehydrogenase cloned in plasmids and a yeast artificial chromosome. Genomics 1991; 10(3): 792.
20. Kääriainen L, Klemola E, Paloheimo J. Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. Br Med J 1966; 5498(1): 1270.
21. Gunter KC. Transfusion-transmitted cytomegalovirus: the part-time pathogen [Review]. Pediatr Pathol Lab Med 1995; 15(3):515.
22. Söderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, Möller E. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993; 67(11): 6576.
23. Giugni TD, Söderberg C, Ham DJ, et al. Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis 1996; 173(5): 1062.
24. Cassol SA, Poon MC, Pal R, et al. Primer-mediated enzymatic amplification of cytomegalovirus (CMV) DNA. Application to the early diagnosis of CMV infection in marrow transplant recipients. J Clin Invest 1989; 83(4): 1109.
25. Bevan IS, Daw RA, Day PJ, Ala FA, Walker MR. Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population. Br J Haematol 1991; 78(1): 94.
26. Stainer P, Taylor DL, Kitchen AD, Wales N, Tryhorn Y, Tyms AS. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ 1989; 299: 897.
27. Smith KL, Kulski JK, Cobain T, Dunstan RA. Detection of cytomegalovirus in blood donors by the polymerase chain reaction. Transfusion 1993; 33(6): 497.
28. Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 1982; 96(2): 149.
29. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153(3): 478.
30. Fish KN, Depto AS, Moses AV, Britt W, Nelson JA. Growth kinetics of human cytomegalovirus are altered in monocytederived macrophages. J Virol 1995; 69(6): 3737.
31. Söderberg-Nauclér C, Fish K, Nelson J. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood from healthy donors. Cell 1997; 91: 119.